Key Drivers
- Solid cash flow
- Thin margins
- Rising leverage
AIAI Summary
HSIC is shifting from a defensive distributor to a self-help story as accelerating internal sales and better execution are starting to lift earnings, but with leverage, thin margins, and a valuation that already prices in much of the good news, the stock now needs sustained margin expansion and clean GAAP follow-through to justify further upside.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Solid cash flow
- •Thin margins
- •Rising leverage
HSIC delivers steady revenue and solid free cash flow with acceptable returns, but thin margins, rising leverage, and a full valuation limit upside.
Price Behavior
Key Price Behavior Insights:
- •Higher-Low Trend
- •Near-Term Resistance
- •Extended Rally
HSIC remains slightly constructive, with higher highs and lows and a breakout above the mid-$80s, but it is now extended and facing resistance near $90-$91.
Broke out above the mid-$80s and reached $90.74 before fading slightly near resistance
Sentiment & News
Key News Insights:
- •Q2 Beat
- •Raised Guidance
- •Momentum Rising
Henry Schein delivered a strong Q2 earnings and revenue beat, raised 2026 guidance, and is seeing improving momentum and investor interest, though valuation remains a key debate.
The headlines are likely supportive for HSIC near term, as stronger fundamentals and upgraded guidance should bolster sentiment, even if valuation caps upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings